Pathologic Examination of Sentinel Lymph Node for Breast Carcinoma

[1]  A. Giuliano,et al.  Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node , 2000, Cancer.

[2]  D. Weaver,et al.  Submission of lymph node tissue for ancillary studies decreases the accuracy of conventional breast cancer axillary node staging. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[3]  A E Giuliano,et al.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? , 1999, Annals of surgery.

[4]  A. Giuliano,et al.  Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. , 1999, The American journal of surgical pathology.

[5]  A. Giuliano,et al.  Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple‐marker RT‐PCR , 1998, International journal of cancer.

[6]  L. Tafra,et al.  Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes. , 1998, Cancer research.

[7]  R. Foster,et al.  The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.

[8]  A. Purushotham,et al.  Lymphatic mapping and sentinel node biopsy in breast cancer. , 1997, JAMA.

[9]  A. Giuliano,et al.  Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  P. Stanton,et al.  Sentinel node localization in patients with breast cancer , 1998, The British journal of surgery.

[11]  D. Cole,et al.  Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. , 1998, Journal of the American College of Surgeons.

[12]  A. Giuliano,et al.  Therapeutic effect of sentinel lymphadenectomy in T1 breast cancer. , 1998, Archives of surgery.

[13]  R. Elashoff,et al.  Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran , 1998, Cancer.

[14]  T. Yeatman,et al.  Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. , 1998, Annals of surgery.

[15]  R. Roumen,et al.  Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  A. Giuliano,et al.  Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. , 1997, Annals of surgery.

[17]  Umberto Veronesi,et al.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes , 1997, The Lancet.

[18]  A E Giuliano,et al.  Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  N. Joste,et al.  The surgical pathology report: Standardizing the “gold standard” , 1997, Journal of surgical oncology.

[20]  T. Yeatman,et al.  Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. , 1996, JAMA.

[21]  R. Turner,et al.  Detection of metastatic breast cancer by β‐hCG polymerase chain reaction , 1996 .

[22]  J. Perkins,et al.  Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  P. Lilleng,et al.  Breast cancer: two micrometastatic variants in the axilla that differ in prognosis , 1996, Histopathology.

[24]  M. Cummings,et al.  Occult axillary node metastases in breast cancer: their detection and prognostic significance. , 1996, British Journal of Cancer.

[25]  A. Giuliano,et al.  Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy , 1995, Annals of surgery.

[26]  M. Cranor,et al.  Epithelial Displacement in Surgical Breast Specimens Following Needling Procedures , 1994, The American journal of surgical pathology.

[27]  Shinzaburo Noguchi,et al.  The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase‐polymerase chain reaction , 1994, Cancer.

[28]  Alice Chung,et al.  Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer , 1994, Annals of surgery.

[29]  F. Menestrina,et al.  A rapid immunostaining method for frozen sections. , 1994, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[30]  S. Shousha,et al.  Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. , 1994, Cancer research.

[31]  D. Weaver,et al.  Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.

[32]  M. Burke,et al.  Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance , 1993, The British journal of surgery.

[33]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[34]  R. Gelber,et al.  Axillary node micrometastases and breast cancer , 1991, The Lancet.

[35]  International Study Group,et al.  Prognostic importance of occult axillary lymph node micrometastases from breast cancers , 1990, The Lancet.

[36]  Internationalludwigbreastcanc.  Prognostic importance of occult axillary lymph node micrometastases from breast cancers , 1990 .

[37]  R. Coombes,et al.  The fate of bone marrow micrometastases in patients with primary breast cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  J. Coindre,et al.  Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. , 1987, British Journal of Cancer.

[39]  F. Hartveit.  The routine histological investigation of axillary lymph nodes for metastatic breast cancer , 1984, The Journal of pathology.

[40]  D. Quill,et al.  Lymph node imprint cytology for the rapid assessment of axillary node metastases in breast cancer , 1984, The British journal of surgery.

[41]  E. Wilkinson,et al.  Probability in lymph node sectioning , 1974, Cancer.

[42]  Qianchuan Zhao,et al.  Prognosis in breast cancer. , 1962, Journal de medecine de Lyon.

[43]  P. Flicek,et al.  Guidelines for the Safe Use of Radioactive Materials During Localization and Resection of the Sentinel Lymph Node , 1999, Annals of Surgical Oncology.

[44]  A. Giuliano,et al.  Radiation Safety Considerations for Sentinel Node Techniques , 1999, Annals of Surgical Oncology.

[45]  F. Vicini,et al.  Prognostic features in patients with stage T1 breast carcinoma and a 0.5-cm or less lymph node metastasis. Significance of lymph node hilar tissue invasion. , 1999, American journal of clinical pathology.

[46]  K. Mimori,et al.  Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  M. Noguchi.  Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. , 1995, The British journal of surgery.

[48]  Shinzaburo Noguchi,et al.  The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase‐polymerase chain reaction , 1995, Cancer.